Pathology • March 9, 2026
The Flow Cytometry Laboratory team presented at the 2025 International Clinical Cytometry Society (ICCS) Annual Meeting. In addition to attending sessions on the latest advances in the field, our team members are proudly representing BIDMC in several key activities. Click the headers to learn more.
Pathology • March 6, 2026
Congratulations to James Kirby, MD, and his team for developing a faster, simpler way to test whether antibiotics will work against drug-resistant bacterial infections. The elegant method could save patients precious time while supporting responsible use of the antibiotic arsenal. In a study published in the Journal of Clinical Microbiology, the team showed that simply changing the materials in a standard lab test to grow bacteria can deliver gold-standard results in a fraction of the time and with less effort. Dr. Kirby is the director of the Clinical Microbiology Laboratory and associate vice chair of Laboratory Medicine at Beth Israel Deaconess Medical Center. Click the header to learn more.
Pathology • March 3, 2026
As part of the Dana-Farber Beth Israel Deaconess Cancer Collaboration, BIDMC, Dana-Farber Cancer Institute (DFCI), and Harvard Medical Faculty Physicians (HMFP) are partnering to build New England’s first and only dedicated, freestanding inpatient hospital for adult cancer patients. Together, we are harnessing next-generation diagnostics and technology to deliver extraordinary, personalized care—and redefine cancer care for the next century. To meet this challenge, we are establishing the Machine Learning Center for Pathology—a secure, pathologist-led research environment designed to drive responsible innovation in anatomic pathology using artificial intelligence (AI). Click the header to read more.
Anesthesia • February 19, 2026
Sara Neves, MD, has been appointed Vice Chair of Professional Affairs for the Department of Anesthesia, Critical Care and Pain Medicine at BIDMC. In this pivotal role, Dr. Neves will oversee clinician recruitment, credentialing, Harvard appointments, career development, and faculty review. Click the header to learn more.
Medicine • February 19, 2026
Douglas Krakower, MD, has been appointed Chief of the Division of Infectious Diseases in the Department of Medicine. As Division Chief, Dr. Krakower will continue his 17-year affiliation with the Division of Infectious Diseases. An outstanding physician and mentor, a renowned researcher in HIV prevention, and a highly effective teacher, Dr. Krakower will continue to foster BIDMC’s culture of excellence in clinical care, research, and education in infectious diseases, while expanding its scope, expertise, and impact. Click the header to learn more.
Pathology • February 11, 2026
The BIDMC Pathology Department is rapidly growing and expanding its faculty, fellowships, programs, lab offerings, research. We’re also proud and excited to be an integral part of the landmark collaboration among Dana-Farber Cancer Institute (DFCI), Beth Israel Deaconess Medical Center (BIDMC), and Harvard Medical Faculty Physicians (HMFP) to establish New England’s only freestanding adult inpatient cancer hospital. The collaboration will provide unparalleled opportunities for pathology and other physician specialties to be part of DFCI’s internationally recognized cancer team.
